{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:07:13Z","timestamp":1789128433383,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jns.2009.09.012","type":"journal-article","created":{"date-parts":[[2009,10,3]],"date-time":"2009-10-03T19:45:46Z","timestamp":1254599146000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Multiple sclerosis, osteoporosis, and vitamin D"],"prefix":"10.1016","volume":"287","author":[{"given":"Chrissa","family":"Sioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios P.","family":"Kyritsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2009.09.012_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002239900309","article-title":"Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid Use","volume":"61","author":"Formica","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jns.2009.09.012_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00774-005-0604-9","article-title":"Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity","volume":"23","author":"Ozgocmen","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jns.2009.09.012_bib3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.51.4.1161","article-title":"Fracture history and bone loss in patients with MS","volume":"51","author":"Cosman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.09.012_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.apmr.2007.10.043","article-title":"Injurious falls among middle aged and older adults with multiple sclerosis","volume":"89","author":"Peterson","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jns.2009.09.012_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4140\/TCP.n.2005.128","article-title":"Osteoporosis in long-term care residents with multiple sclerosis","volume":"20","author":"Faulkner","year":"2005","journal-title":"Consult Pharm"},{"key":"10.1016\/j.jns.2009.09.012_bib6","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis","volume":"44","author":"Nieves","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.09.012_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/1352458504ms993oa","article-title":"Risk of bone loss in men with multiple sclerosis","volume":"10","author":"Weinstock-Guttman","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2009.09.012_bib8","first-page":"901","article-title":"Bone mineral density in patients with multiple sclerosis: The effects of interferon","volume":"36","author":"Perez Castrillon","year":"2003","journal-title":"Rev Neurol"},{"key":"10.1016\/j.jns.2009.09.012_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11845-008-0253-9","article-title":"Favorable effect of immunomodulator therapy on bone mineral density in multiple sclerosis","volume":"178","author":"Shuhaibar","year":"2009","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.jns.2009.09.012_bib10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1331.2005.00988.x","article-title":"Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis","volume":"12","author":"Zorzon","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2009.09.012_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cccn.2004.05.012","article-title":"Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids","volume":"348","author":"Stepan","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jns.2009.09.012_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.1996.00550080071014","article-title":"Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis","volume":"53","author":"Schwid","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.09.012_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2008.08.031","article-title":"The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis?","volume":"276","author":"Altintas","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.09.012_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1191\/1352458503ms966oa","article-title":"Bone status in multiple sclerosis: beyond corticosteroids","volume":"9","author":"Tuzun","year":"2003","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2009.09.012_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/qjmed\/hci135","article-title":"Are multiple sclerosis patients risk-takers?","volume":"98","author":"Hawkes","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.jns.2009.09.012_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/QCO.0b013e3282f88b48","article-title":"Multiple sclerosis: immunopathogenesis and controversies in defining the cause","volume":"21","author":"Holmoy","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jns.2009.09.012_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000122330","article-title":"Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway","volume":"30","author":"Kampman","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2009.09.012_bib18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.wco.0000227033.47458.82","article-title":"Epidemiology and natural history of multiple sclerosis: new insights","volume":"19","author":"Kantarci","year":"2006","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jns.2009.09.012_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.2008.01029.x","article-title":"Environmental risk factors in multiple sclerosis","volume":"188","author":"Pugliatti","year":"2008","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.jns.2009.09.012_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00415-006-0395-5","article-title":"Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle","volume":"254","author":"Kampman","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2009.09.012_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1039\/b700018a","article-title":"The effects on human health from stratospheric ozone depletion and its interactions with climate change","volume":"6","author":"Norval","year":"2007","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.jns.2009.09.012_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0300-483X(02)00257-3","article-title":"Ultraviolet radiation and autoimmune disease: insights from epidemiological research","volume":"181\u2013182","author":"Ponsonby","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.jns.2009.09.012_bib23","first-page":"2581","article-title":"Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases","volume":"26","author":"Peterlik","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jns.2009.09.012_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ncprheum0855","article-title":"Control of autoimmune diseases by the vitamin D endocrine system","volume":"4","author":"Adorini","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jns.2009.09.012_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2007-1019126","article-title":"Epidemiology of multiple sclerosis: from risk factors to prevention","volume":"28","author":"Ascherio","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jns.2009.09.012_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2009.09.012_bib27","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/01.SMJ.0000140865.32054.DB","article-title":"Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers","volume":"98","author":"Holick","year":"2005","journal-title":"South Med J"},{"key":"10.1016\/j.jns.2009.09.012_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1099800407308057","article-title":"The effects of vitamin D deficiency and insufficiency on the endocrine and paracrine systems","volume":"9","author":"Alpert","year":"2007","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.jns.2009.09.012_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.mam.2008.08.005","article-title":"Geographic location and vitamin D synthesis","volume":"29","author":"Kimlin","year":"2008","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jns.2009.09.012_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbiomolbio.2006.02.016","article-title":"Vitamin D physiology","volume":"92","author":"Lips","year":"2006","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.jns.2009.09.012_bib31","first-page":"277","article-title":"The immunological functions of the vitamin D endocrine system","volume":"49","author":"Hayes","year":"2003","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.jns.2009.09.012_bib32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/ard.2007.069831","article-title":"Vitamin D and autoimmunity: new aetiological and therapeutic considerations","volume":"66","author":"Arnson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jns.2009.09.012_bib33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q","article-title":"Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1, 25-dihydroxyvitamin D(3)","volume":"30","author":"Mattner","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jns.2009.09.012_bib34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1345\/aph.1G513","article-title":"The role of vitamin D in multiple sclerosis","volume":"40","author":"Brown","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jns.2009.09.012_bib35","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1111\/j.1753-4887.2008.00097.x","article-title":"Vitamin D and multiple sclerosis: an update","volume":"66","author":"Cantorna","year":"2008","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jns.2009.09.012_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pbiomolbio.2006.02.013","article-title":"Epidemiology of disease risks in relation to vitamin D insufficiency","volume":"92","author":"Grant","year":"2006","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.jns.2009.09.012_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbiomolbio.2009.02.003","article-title":"Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe","author":"Grant","year":"2009","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.jns.2009.09.012_bib38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jada.2005.12.009","article-title":"Vitamin D and autoimmune disease\u2013implications for practice from the multiple sclerosis literature","volume":"106","author":"Mark","year":"2006","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jns.2009.09.012_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jcb.21858","article-title":"Vitamin D and multiple sclerosis","volume":"105","author":"Raghuwanshi","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jns.2009.09.012_bib40","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/jnr.21382","article-title":"1, 25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking","volume":"85","author":"Pedersen","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2009.09.012_bib41","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/jnr.20826","article-title":"1, 25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12\/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis","volume":"83","author":"Muthian","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2009.09.012_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2332\/allergolint.R-07-159","article-title":"Th17 Cells and autoimmune encephalomyelitis (EAE\/MS)","volume":"57","author":"Aranami","year":"2008","journal-title":"Allergol Intern"},{"key":"10.1016\/j.jns.2009.09.012_bib43","doi-asserted-by":"crossref","first-page":"e1000369","DOI":"10.1371\/journal.pgen.1000369","article-title":"Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D","volume":"5","author":"Ramagopalan","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jns.2009.09.012_bib44","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1073\/pnas.082100699","article-title":"CD8(+) T cells are not necessary for 1 alpha, 25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice","volume":"99","author":"Meehan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2009.09.012_bib45","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.4049\/jimmunol.177.9.6030","article-title":"IL-10 signaling is essential for 1, 25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis","volume":"177","author":"Spach","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2009.09.012_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1152\/physiolgenomics.00003.2004","article-title":"Gene expression analysis suggests that 1, 25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis","volume":"18","author":"Spach","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jns.2009.09.012_bib47","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jsbmb.2006.12.094","article-title":"Novel insights in the immune function of the vitamin D system: synergism with interferon-beta","volume":"103","author":"van Etten","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jns.2009.09.012_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2009.02.009","article-title":"The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis","author":"Smolders","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jns.2009.09.012_bib49","first-page":"4639","article-title":"Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population","volume":"85","author":"Ban","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jns.2009.09.012_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(99)00112-4","article-title":"Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese","volume":"166","author":"Fukazawa","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.09.012_bib51","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1352458509102459","article-title":"Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction","volume":"15","author":"Dickinson","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2009.09.012_bib52","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1177\/1352458508094643","article-title":"Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis","volume":"14","author":"Mamutse","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2009.09.012_bib53","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1212\/WNL.62.12.2323","article-title":"Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes","volume":"62","author":"Partridge","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.09.012_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2008.12.011","article-title":"Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis","volume":"207","author":"Smolders","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2009.09.012_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-510X(00)00336-1","article-title":"Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles","volume":"177","author":"Niino","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.09.012_bib56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/01.wnl.0000323928.57408.93","article-title":"Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis","volume":"71","author":"Dwyer","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.09.012_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2006.03.011","article-title":"Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism","volume":"372","author":"Speeckaert","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jns.2009.09.012_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-5728(02)00099-1","article-title":"No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS","volume":"127","author":"Niino","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2009.09.012_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10571-008-9312-z","article-title":"Alteration of DBP levels in CSF of patients with MS by proteomics analysis","volume":"29","author":"Qin","year":"2009","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.jns.2009.09.012_bib60","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2174\/092986708783503159","article-title":"Therapeutic potential of vitamin D for multiple sclerosis","volume":"15","author":"Niino","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jns.2009.09.012_bib61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.09.012_bib62","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-5728(99)00247-7","article-title":"1, 25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis","volume":"103","author":"Nashold","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2009.09.012_bib63","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2009.09.012_bib64","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/1352458506072666","article-title":"Assessment of 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers","volume":"13","author":"Barnes","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2009.09.012_bib65","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of Vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jns.2009.09.012_bib66","doi-asserted-by":"crossref","DOI":"10.1177\/1352458509102844","article-title":"Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis","author":"Hiremath","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2009.09.012_bib67","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1191\/1352458505ms1157oa","article-title":"25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis","volume":"11","author":"Soilu-Hanninen","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2009.09.012_bib68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1445-5994.2007.01339.x","article-title":"Vitamin D deficiency in general medical inpatients in summer and winter","volume":"37","author":"Chatfield","year":"2007","journal-title":"Intern Med J"},{"key":"10.1016\/j.jns.2009.09.012_bib69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000166602","article-title":"Monthly ambient sunlight, infections and relapse rates in multiple sclerosis","volume":"31","author":"Tremlett","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2009.09.012_bib70","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00415-006-0315-8","article-title":"Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia","volume":"254","author":"van der Mei","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2009.09.012_bib71","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp.2006.105320","article-title":"A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis","volume":"79","author":"Soilu-Hanninen","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.09.012_bib72","first-page":"6","article-title":"Use of vitamin D in clinical practice","volume":"13","author":"Cannell","year":"2008","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.jns.2009.09.012_bib73","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1179\/174313208X325038","article-title":"Examining the evidence: complementary adjunctive therapies for multiple sclerosis","volume":"30","author":"Namaka","year":"2008","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2009.09.012_bib74","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jsbmb.2004.03.038","article-title":"Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults","volume":"89\u201390","author":"Vieth","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jns.2009.09.012_bib75","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1079\/BJN2003837","article-title":"Vitamin D in preventive medicine: are we ignoring the evidence?","volume":"89","author":"Zittermann","year":"2003","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jns.2009.09.012_bib76","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ajcn\/69.5.842","article-title":"Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety","volume":"69","author":"Vieth","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jns.2009.09.012_bib77","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","article-title":"A pilot study of oral calcitriol (1, 25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis","volume":"76","author":"Wingerchuk","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.09.012_bib78","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcn\/86.3.645","article-title":"Safety of vitamin D3 in adults with multiple sclerosis","volume":"86","author":"Kimball","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jns.2009.09.012_bib79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/01677060590949692","article-title":"Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population","volume":"19","author":"Tajouri","year":"2005","journal-title":"J Neurogenet"},{"key":"10.1016\/j.jns.2009.09.012_bib80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1352458508095920","article-title":"Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women","volume":"15","author":"Kragt","year":"2009","journal-title":"Mult Scler"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09008545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09008545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:38:54Z","timestamp":1758382734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X09008545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":80,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0022510X09008545"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2009.09.012","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis, osteoporosis, and vitamin D","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2009.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}